Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2026 Earnings Call Transcript
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2026 Earnings Call Transcript May 5, 2026Arcus Biosciences, Inc. misses on earnings expectations.
Posts Tagged ‘NYSE:RCUS’
Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2025 Earnings Call Transcript
Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2025 Earnings Call Transcript February 25, 2026Arcus Biosciences, Inc. beats earnings expectations.
Here’s What Analysts Think About Arcus Biosciences (RCUS)
Arcus Biosciences, Inc. (NYSE:RCUS) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Arcus Biosciences, Inc.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Arcus Biosciences Inc. (RCUS) Posts Positive Results on Kidney Cancer Drug Trials
Arcus Biosciences Inc. (NYSE:RCUS) is one of billionaire Steve Cohen’s 10 small-cap stock picks with huge upside potential. On October 6, Arcus Biosciences Inc.
Billionaire Steve Cohen’s 10 Small-Cap Stock Picks with Huge Upside Potential
Known for speed, agility, and a high-risk, high-reward investment approach, Steve Cohen is one of the most successful hedge fund managers on Wall Street.
Jim Cramer Shed Light on These 14 Stocks
“Right now, it is a wild chase, a mad dash so to speak, to make money wherever it can be found, IPOs, mergers and acquisitions, giant upside surprises.
Arcus Biosciences’ Pancreatic Cancer Drug Quemliclustat Receives Orphan Drug Designation from FDA
Arcus Biosciences Inc. (NYSE:RCUS) is one of the biotech stocks to buy according to Wall Street analysts.
10 Biotech Stocks to Buy According to Wall Street Analysts
On July 8, Jared Holz, Mizuho, joined 'Closing Bell Overtime' on CNBC to discuss if the biotech sector is ready for a breakout.
12 Small Cap Stocks with High Upside Potential
The trade war saga between the U.S. and China appears to be nearing a conclusion, as China’s Ministry of Commerce shared details on the trade deal on June 27.
Arcus Biosciences Presents First Postive Data for Oral Metastatic Kidney Cancer Treatment
Arcus Biosciences, Inc. (NYSE:RCUS) is one of the 12 Small Cap Stocks with High Upside Potential.
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2025 Earnings Call Transcript
Operator: Hello, everyone. And welcome to Arcus Biosciences First Quarter 2025 Earnings and Financial Results Call. My name is Lydia, and I'll be your operator today.
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2024 Earnings Call Transcript
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2024 Earnings Call Transcript November 6, 2024Arcus Biosciences, Inc. beats earnings expectations.
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript
Arcus Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.97. Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript
Operator: Hello and welcome to the Arcus Biosciences Full Year/Q4 2023 Earnings Call. My name is Elliot, and I’ll be coordinating your call today. [Operator Instructions].
Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2023 Earnings Call Transcript
Operator: Thank you and welcome to the call. Following prepared remarks from the Company, we will open the call for questions.
Trending Stocks on Tuesday: Top 10 Gainers
In this article, we will discuss some of the notable stocks trending today.
Hedge Funds Are Selling Arcus Biosciences, Inc. (RCUS)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
10 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.
Hedge Funds Are Cashing Out Of Arcus Biosciences, Inc. (RCUS)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is Arcus Biosciences, Inc. (RCUS) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund and Insider Trading News: Carl Icahn, Steve Cohen, Alden Global Capital, Archegos Capital, Apollo Global Management, Arcus Biosciences Inc (RCUS), Starbucks Corporation (SBUX), and More
NEW YORK (Reuters Breakingviews) - DEALING AND WHEELING. Carl Icahn’s listed fund has a new leading man.
Hedge Funds Keep Buying Arcus Biosciences, Inc. (RCUS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Arcus Biosciences, Inc. (RCUS) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Have Never Been This Bullish On Arcus Biosciences, Inc. (RCUS)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Is Arcus Biosciences, Inc. (NYSE:RCUS) A Good Stock To Buy?
Does Arcus Biosciences, Inc. (NYSE:RCUS) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
Arcus Biosciences, Inc. (RCUS): Hedge Funds Are Snapping Up
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Arcus Biosciences, Inc. (RCUS) A Good Stock To Buy?
Is Arcus Biosciences, Inc. (NYSE:RCUS) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Hedge Fund and Insider Trading News: D.E. Shaw, Appaloosa Management, Bill Ackman, Arcus Biosciences Inc (RCUS), SCYNEXIS Inc (SCYX), RealNetworks Inc (RNWK), and More
Several prominent hedge funds could be among investors feeling the pain from Facebook Inc.’s recent plunge amid the Cambridge Analytica data crisis.
Hedge Fund Resource Center
